Diagnostic Kits/IP Profile of Universities working in Kits: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
Pressman Article...
Pressman Article...


*Henry, M.R., Cho, M.K., Weaver, M.A., Merz, J.F. A pilot survey on the licensing of DNA inventions. J. Law Med. Ethics, 31:442-449, 2003 Available at: http://www.bioethics.upenn.edu:16080/prog/ethicsgenes/


 
A pilot survey on the licensing of DNA inventions focuses on the: ([[Diagnostic Kits/A pilot survey on the licensing of DNA inventions|(Henry, M.R., et al., 2003)]])
A pilot survey on the licensing of DNA inventions focuses on the: ([[Diagnostic Kits/The licensing of DNA patents by US academic institutions|(Henry, M.R., et al., 2003)]])
**patenting and out-licensing strategies
**patenting and out-licensing strategies
**licensing negotiations: exclusivity, uses, and terms
**licensing negotiations: exclusivity, uses, and terms
Line 21: Line 19:
***For profits more often fill patent applications for all new technologies and then deciding what to pursue based on commercial interest.   
***For profits more often fill patent applications for all new technologies and then deciding what to pursue based on commercial interest.   
***Non-profits were more selective about when to apply for a patent.   
***Non-profits were more selective about when to apply for a patent.   
**Licensing Behavior ([[Diagnostic Kits/The licensing of DNA patents by US academic institutions|(Henry, M.R., et al., 2003)]])
**Licensing Behavior ([[Diagnostic Kits/A pilot survey on the licensing of DNA inventions|(Henry, M.R., et al., 2003)]])
***For both entities, licensing was most often used as a method of commercialization.  Licensing for research was very infrequent.
***For both entities, licensing was most often used as a method of commercialization.  Licensing for research was very infrequent.
***One important difference found was that nonprofits were more than twice as likely to license exclusively as compared to for-profit companies.
***One important difference found was that nonprofits were more than twice as likely to license exclusively as compared to for-profit companies.

Revision as of 14:41, 11 September 2009

Answer the questions:

  1. What are the 5 top Universities in this field?
    • Correlate them with their main outputs (Data. Narratives. Tools)
    • Understand and identify cases where these universities are “experimenting” or “adopting” commons based approach. Are they adopting OA policies, for instance? Are they adopting Social Responsible License approaches?
    • Identify these cases and treat them as entities that will also be placed in our mapping device (the quadrants)
    • Identify what universities are the “Microsofts” of the field and what companies are the “IBMs” of the field (Use the questionnaire to guide your research when appropriate - Carol will select specific relevant questions)

Pressman Article...


A pilot survey on the licensing of DNA inventions focuses on the: ((Henry, M.R., et al., 2003))

    • patenting and out-licensing strategies
    • licensing negotiations: exclusivity, uses, and terms
    • Protection of non-patented technologies: MTAs, NDAs
  • Institutions chosen for the study had patents of inventions using human DNA and both for profit and non-profits were sampled. The study found that for profit and non-profit entities approach patent and licenses differently:
    • Patenting Behavior ((Henry, M.R., et al., 2003))
      • For profits more often fill patent applications for all new technologies and then deciding what to pursue based on commercial interest.
      • Non-profits were more selective about when to apply for a patent.
    • Licensing Behavior ((Henry, M.R., et al., 2003))
      • For both entities, licensing was most often used as a method of commercialization. Licensing for research was very infrequent.
      • One important difference found was that nonprofits were more than twice as likely to license exclusively as compared to for-profit companies.

Navigation

Main Page Diagnostic_Kits